Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onartuzumab plus paclitaxel-platinum vs placebo plus paclitaxel-platinum in squamous non-small cell lung cancer
2011-003720-12Phase 2Completed
- Sponsor
- Roche
- Start
- Mar 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Pulmonary squamous cell carcinoma comparing MetMAb + paclitaxel + platinum with Placebo + paclitaxel + platinum (2 arms). Primary endpoint: Progression-free survival (PFS). Started Mar 2012; status: completed.
02
Drugs
onartuzumab
03
Conditions
Pulmonary squamous cell carcinoma
Beyond the preview
Go deeper on 2011-003720-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003720-12.